Canaccord Genuity Maintains Buy on OrthoPediatrics, Raises Price Target to $30

Benzinga · 2d ago
Canaccord Genuity analyst Caitlin Roberts maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $28 to $30.